Glutathione in Health and Disease: Pharmacotherapeutic Issues
- 1 December 1995
- journal article
- review article
- Published by SAGE Publications in Annals of Pharmacotherapy
- Vol. 29 (12) , 1263-1273
- https://doi.org/10.1177/106002809502901213
Abstract
Objective: To review the current research and importance of glutathione (GSH) therapy in health and disease and to provide a basic overview of the widespread use and interest in this compound. Data Identification: Articles were obtained via a MEDLINE search of the term glutathione in conjunction with specific disease states mentioned, and via extensive review of references found in articles identified by computer search. Study Selection: Emphasis was placed on the most recent research, human research, and in discussing multiple disease states. Data Extraction: The literature was reviewed for methodology, quality, and practical aspects of interest to clinical pharmacists. Data Synthesis: GSH is a tripeptide of extreme importance as a catalyst, reductant, and reactant. It continues to be investigated in diverse areas such as acute respiratory distress syndrome, toxicology, AIDS, aging, oncology, and liver disease. Despite the widespread clinical interest in GSH, we were not able to identify an in-depth review of this compound in the pharmacy literature. Conclusions: The list of potential indications for modulation of GSH is extensive and broad. This review introduces clinicians to what GSH is, its basic chemistry, and some areas of active research.Keywords
This publication has 76 references indexed in Scilit:
- CYCLOSPORINE NEPHROTOXICITY: ATTENUATION BY AN ANTIOXIDANT-INHIBITOR OF LIPID PEROXIDATION IN VITRO AND IN VIVOTransplantation, 1994
- Role of iron and glutathione redox cycle in acetaminophen-induced cytotoxicity to cultured rat hepatocytesDigestive Diseases and Sciences, 1994
- Glutathione in foods listed in the national cancer institute's health habits and history food frequency questionnaireNutrition and Cancer, 1992
- Oral glutathione increases tissue glutathione in vivoChemico-Biological Interactions, 1991
- Metabolism of Exogenous S-Adenosyl-L-Methionine in Patients with Liver DiseaseDrugs, 1990
- Role of S-Adenosyl-L-Methionine in the Treatment of Intrahepatic CholestasisDrugs, 1990
- Biochemistry and Pharmacology of S-Adenosyl-L-Methionine and Rationale for its Use in Liver DiseaseDrugs, 1990
- S-Adenosyl-L-MethionineDrugs, 1989
- Mitochondrial damage in muscle occurs after marked depletion of glutathione and is prevented by giving glutathione monoester.Proceedings of the National Academy of Sciences, 1989
- Hepatic glutathione content in patients with alcoholic and non alcoholic liver diseasesLife Sciences, 1988